Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator

Europace

Volumn 10, Issue 3, 2008, Pages 358-363

  Gardiwal, Ajmal ^a   Yu, Hong ^a   Oswald, Hanno ^a   Luesebrink, Ulrich ^a   Ludwig, Andreas ^a   Pichlmaier, Andreas Maximilian ^a   Drexler, Helmut ^a   Klein, Gunnar ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Heart failure; ICD; Right ventricular pacing; VT VF

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ANAMNESIS; ARTICLE; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PACING; HEART SURGERY; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; QRS COMPLEX; RIGHT VENTRICULAR PACING; SURGICAL MORTALITY; SURGICAL TECHNIQUE;

AGED; ALGORITHMS; CARDIAC PACING, ARTIFICIAL; COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART VENTRICLES; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 44649196573     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun019     Document Type: Article

References (31)

1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
2. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators. N Engl J Med 1996;335:1933-40.
3. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
4. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter unsustained tachycardia trial investigators. N Engl J Med 1999;341:1882-90.
5. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004;351:2481-8.
6. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002;288:3115-23.
7. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA et al. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Am Coll Cardiol 2002;40:1703-19.
8. Korte T, Jung W, Ostermann G, Wolpert C, Spehl S, Esmailzadeh B et al. Hospital readmission after transvenous cardioverter/defibrillator implantation; a single centre study. Eur Heart J 2000;21:1186-91.
9. Kies P, Boersma E, Bax JJ, van der Burg AE, Bootsma M, Van EL et al. Determinants of recurrent ventricular arrhythmia or death in 300 consecutive patients with ischemic heart disease who experienced aborted sudden death: data from the Leiden out-of-hospital cardiac arrest study. J Cardiovasc Electrophysiol 2005;16:1049-56.
10. Ohno J, Watanabe E, Toyama J, Kawamura T, Ohno M, Kodama I. Risk stratification and survival in post myocardial infarction patients: a large prospective and multicenter study in Japan. Int J Cardiol 2004;93:263-8.
11. Caruso AC, Marcus FI, Hahn EA, Hartz VL, Mason JW. Predictors of arrhythmic death and cardiac arrest in the ESVEM trial. Electrophysiologic Study Versus Electromagnetic Monitoring. Circulation 1997;96:1888-92.
12. De SJ, Kazmierczak J, Fonteyne W, Tavernier R, Jordaens LJ. Factors determining long-term outcomes and survival in patients with coronary artery disease and ventricular tachyarrhythmias: a single center experience. Pacing Clin Electrophysiol 2000;23:1947-52.
13. Stecker EC, Zargarian M, Dogra V, John BT, Kron J, McAnulty JH et al. Native QRS duration predicts the occurrence of arrhythmic events in ICD recipients. Europace 2006;8:859-62.
14. Whang W, Mittleman MA, Rich DQ, Wang PJ, Ruskin JN, Tofler GH et al. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study. Circulation 2004;109:1386-91.
15. Verma A, Kilicaslan F, Martin DO, Minor S, Starling R, Marrouche NF et al. Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies. Heart 2006;92:190-5.
16. Yu H, Oswald H, Gardiwal A, Lissel C, Klein G. Comparison of N-Terminal Pro-Brain Natriuretic Peptide versus Electrophysiological Study for predicting future outcomes in patients with an implantable cardioverter defibrillator after myocardial infarction. 2007 (Ref Type: Generic).
17. Klein G, Lissel C, Fuchs AC, Gardiwal A, Oswald H, Desousa M et al. Predictors of VT/VF-occurrence in ICD patients: results from the PROFITStudy. Europace 2006;8:618-24.
18. Gronefeld GC, Mauss O, Li YG, Klingenheben T, Hohnloser SH. Association between atrial fibrillation and appropriate implantable cardioverter defibrillator therapy: results from a prospective study. J Cardiovasc Electrophysiol 2000;11:1208-14.
19. Bettencourt P, Azevedo A, Pimenta J, Frioes F, Ferreira S, Ferreira A. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 2004;110:2168-74.
20. Korte T, Koditz H, Niehaus M, Paul T, Tebbenjohanns J. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator. Pacing Clin Electrophysiol 2004;27:924-32.
21. Steinberg JS, Fischer A, Wang P, Schuger C, Daubert J, McNitt S et al. The clinical implications of cumulative right ventricular pacing in the multicenter automatic defibrillator trial II. J Cardiovasc Electrophysiol 2005;16:359-65.
22. Smit MD, Van Dessel PF, Nieuwland W, Wiesfeld AC, Tan ES, Anthonio RL et al. Right ventricular pacing and the risk of heart failure in implantable cardioverter-defibrillator patients. Heart Rhythm 2006;3:1397-403.
23. Olshansky B, Day JD, Lerew DR, Brown S, Stolen KQ. Eliminating right ventricular pacing may not be best for patients requiring implantable cardioverter-defibrillators. Heart Rhythm 2007;4:886-91.
24. Kass DA. Pathophysiology of physiologic cardiac pacing: advantages of leaving well enough alone. JAMA 2002;288:3159-61.
25. Goldberger JJ, Kadish AH. Cardiac memory. Pacing Clin Electrophysiol 1999;22:1672-9.
26. van Oosterhout MF, Prinzen FW, Arts T, Schreuder JJ, Vanagt WY, Cleutjens JP et al. Asynchronous electrical activation induces asymmetrical hypertrophy of the left ventricular wall. Circulation 1998;98:588-95.
27. Adomian GE, Beazell J. Myofibrillar disarray produced in normal hearts by chronic electrical pacing. Am Heart J 1986;112:79-83.
28. Lee MA, Dae MW, Langberg JJ, Griffin JC, Chin MC, Finkbeiner WE et al. Effects of long-term right ventricular apical pacing on left ventricular perfusion, innervation, function and histology. J Am Coll Cardiol 1994;24:225-32.
29. Himmrich E, Przibille O, Zellerhoff C, Liebrich A, Rosocha S, Andreas K et al. Proarrhythmic effect of pacemaker stimulation in patients with implanted cardioverter-defibrillators. Circulation 2003;108:192-7.
30. Doshi RN, Daoud EG, Fellows C, Turk K, Duran A, Hamdan MH et al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol 2005;16:1160-5.
31. Leclercq C, Cazeau S, Lellouche D, Fossati F, Anselme F, Davy JM et al. Upgrading from single chamber right ventricular to biventricular pacing in permanently paced patients with worsening heart failure: The RD-CHF Study. Pacing Clin Electrophysiol 2007;30:S23-S30.